skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

799 Total results for product and free and sample content found

Scrip

What’s In Store For Roche’s New India Boss?

By Anju Ghangurde 16 Nov 2017

Lara Bezerra moves from turbulent Venezuela to head Roche in India. Scrip highlights what the incoming Roche boss might expect on the generally peaceful yet complex Indian market.

Scrip

What’s In Store For Roche’s New India Boss?

By Anju Ghangurde 16 Nov 2017

Lara Bezerra moves from turbulent Venezuela to head Roche in India. Scrip highlights what the incoming Roche boss might expect on the generally peaceful yet complex Indian market.

Pink Sheet

OMB's Grogan Talks Drug Pricing And Taking On 'Sacred Cows'

By Cathy Kelly 16 Nov 2017

Concerns with promoting competition and reducing consumers' 'pain in the pocketbook' are key tenets of the Trump Administration's approach. 

Topic Reimbursement

Pink Sheet

Political Bargaining Intensifies In Final Days Before Vote On EMA’s New Home"

By Ian Schofield 16 Nov 2017

In the run-up to next Monday’s vote on the EMA’s future home, political horse-trading and vote-swapping behind the scenes.

Topic Brexit

Pink Sheet

Novel Biologics Will Get Suffixes (Or At Least One Did)

16 Nov 2017

US FDA's approval of Ultragenyx's Mepsevii (vestronidase alfa-vjbk) marks first novel biologic with a suffix.

Topic Drug review

Scrip

FDA Approves First Digital Pill: Otsuka/Proteus' Abilify MyCite

By Mandy Jackson 16 Nov 2017

Otsuka plans a slow, measured launch of Abilify MyCite, developed with Proteus Health. The product includes an ingested sensor.

Topic FDA

Scrip

Deal Watch: Boehringer’s Hectic Stretch Adds Up To Five Deals

By Joseph Haas 14 Nov 2017

Following its partnership with Dicerna, the German pharma signs a second NASH deal with MiNA and inks three cancer-related transactions, including divestitures. Also, Amgen buys out Kirin’s half of their joint venture for $780m.

Topic Business strategies

Scrip

The Endometriosis Challenge

By Eleanor Malone 14 Nov 2017

Emerging Company Profile: Finland's Forendo Pharma hopes an imminent improvement in diagnostic possibilities will eventually help it commercialize a drug for endometriosis.

Topic Research

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: